Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Winn

Showing results (101-110 of 175) with videos related to

Pageof 18
Sort By:
Journal of Molecular Biology|May 12, 2004
The chromosome of Shigella flexneri bacteriophage Sf6: complete nucleotide sequence, genetic mosaicism, and DNA packagingSherwood Casjens, Danella A Winn-Stapley, Eddie B Gilcrease, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 15, 2023
Advancing More Equitable Care Through the Development of a Health Equity Report CardAlyssa A Schatz, Shonta Chambers, Gretchen C Wartman, et al.
Health Equity|March 6, 2023
Associations in Cigarette Smoking and Health Conditions by Race/Ethnicity Among a Diverse Sample of Patients Receiving Treatment in a Federally Qualified Health Care Setting in ChicagoLarisa A Burke, Alana D Steffen, Sandeep Kataria, et al.
Nature Communications|August 21, 2025
Multi-scale and multi-context interpretable mapping of cell states across heterogeneous spatial samplesPatrick C N Martin, Wenqi Wang, Hyobin Kim, et al.
Plos One|November 9, 2013
Heterotrimeric G-protein, Gα16, is a critical downstream effector of non-canonical Wnt signaling and a potent inhibitor of transformed cell growth in non small cell lung cancerSreedevi Avasarala, Rama Kamesh Bikkavilli, Michelle Van Scoyk, et al.
Neoplasia (New York, N.Y.)|September 7, 2012
Stromal cell-derived factor 1α mediates resistance to mTOR-directed therapy in pancreatic cancerColin D Weekes, Dongweon Song, John Arcaroli, et al.
Molecular Pharmacology|December 7, 2007
Antitumorigenic effects of peroxisome proliferator-activated receptor-gamma in non-small-cell lung cancer cells are mediated by suppression of cyclooxygenase-2 via inhibition of nuclear factor-kappaBYvette Bren-Mattison, Amy M Meyer, Vicki Van Putten, et al.
Journal of Women'S Health (2002)|March 10, 2023
Does the Vaginal Microbiome Operate Differently by Race to Influence Risk of Precervical Cancer?Katherine Y Tossas, Bin Zhu, Robert A Perera, et al.
Neoplasia (New York, N.Y.)|March 18, 2010
Prostacyclin inhibits non-small cell lung cancer growth by a frizzled 9-dependent pathway that is blocked by secreted frizzled-related protein 1Meredith A Tennis, Michelle Van Scoyk, Lynn E Heasley, et al.
Cancer Research|February 12, 2009
Depletion of cytosolic phospholipase A2 in bone marrow-derived macrophages protects against lung cancer progression and metastasisMary C M Weiser-Evans, Xue-Qing Wang, Jay Amin, et al.
Pageof 18

Showing results (101-110 of 175) with videos related to

Sort By:
Pageof 18
Journal of Molecular Biology|May 12, 2004
The chromosome of Shigella flexneri bacteriophage Sf6: complete nucleotide sequence, genetic mosaicism, and DNA packagingSherwood Casjens, Danella A Winn-Stapley, Eddie B Gilcrease, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 15, 2023
Advancing More Equitable Care Through the Development of a Health Equity Report CardAlyssa A Schatz, Shonta Chambers, Gretchen C Wartman, et al.
Health Equity|March 6, 2023
Associations in Cigarette Smoking and Health Conditions by Race/Ethnicity Among a Diverse Sample of Patients Receiving Treatment in a Federally Qualified Health Care Setting in ChicagoLarisa A Burke, Alana D Steffen, Sandeep Kataria, et al.
Nature Communications|August 21, 2025
Multi-scale and multi-context interpretable mapping of cell states across heterogeneous spatial samplesPatrick C N Martin, Wenqi Wang, Hyobin Kim, et al.
Plos One|November 9, 2013
Heterotrimeric G-protein, Gα16, is a critical downstream effector of non-canonical Wnt signaling and a potent inhibitor of transformed cell growth in non small cell lung cancerSreedevi Avasarala, Rama Kamesh Bikkavilli, Michelle Van Scoyk, et al.
Neoplasia (New York, N.Y.)|September 7, 2012
Stromal cell-derived factor 1α mediates resistance to mTOR-directed therapy in pancreatic cancerColin D Weekes, Dongweon Song, John Arcaroli, et al.
Molecular Pharmacology|December 7, 2007
Antitumorigenic effects of peroxisome proliferator-activated receptor-gamma in non-small-cell lung cancer cells are mediated by suppression of cyclooxygenase-2 via inhibition of nuclear factor-kappaBYvette Bren-Mattison, Amy M Meyer, Vicki Van Putten, et al.
Journal of Women'S Health (2002)|March 10, 2023
Does the Vaginal Microbiome Operate Differently by Race to Influence Risk of Precervical Cancer?Katherine Y Tossas, Bin Zhu, Robert A Perera, et al.
Neoplasia (New York, N.Y.)|March 18, 2010
Prostacyclin inhibits non-small cell lung cancer growth by a frizzled 9-dependent pathway that is blocked by secreted frizzled-related protein 1Meredith A Tennis, Michelle Van Scoyk, Lynn E Heasley, et al.
Cancer Research|February 12, 2009
Depletion of cytosolic phospholipase A2 in bone marrow-derived macrophages protects against lung cancer progression and metastasisMary C M Weiser-Evans, Xue-Qing Wang, Jay Amin, et al.
Pageof 18